Boston Scientific Corp (BSX) Stock Price, Quote & News

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal sur...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 683 4000

Website: www.bostonscientific.com

Address:

300 Boston Scientific Way, Marlborough, United States

DragonAlgo Feb. 25 at 12:01 AM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-03-20 | Strike: $75.00 | Type: CALL Option Plan (premium): Entry: $2.53 Stop: $1.82 TP1: $3.28 TP2: $4.29 TP3: $6.06 🔗 https://dragonalgo.com

0 · Reply

Stonkapedia Feb. 24 at 8:53 PM

$BSX close green you dog. Show signs of life.

0 · Reply

_TP888 Feb. 24 at 6:55 PM

$BSX | $78.00 | Call | Premium: $135K Ask-heavy - aggressive call buyers.

0 · Reply

RonnieJamesDevo Feb. 24 at 5:28 PM

$BSX THY GAP SHALL FILL $BSX

0 · Reply

DragonAlgo Feb. 24 at 5:08 AM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-03-20 | Strike: $75.00 | Type: CALL Option Plan (premium): Entry: $2.05 Stop: $1.48 TP1: $2.67 TP2: $3.48 TP3: $4.92 🔗 https://dragonalgo.com

0 · Reply

TitsMcGeee Feb. 23 at 11:44 PM

$BSX @Steward59 Muted. This guys is off his meds. Posts everyday multiple times a day to himself how much he loves this stock, now has flipped sides. Good thing the useless posts seem to continue.

1 · Reply

Steward59 Feb. 23 at 8:50 PM

$BSX don’t trust this company anymore

2 · Reply

BlackjackAces Feb. 23 at 1:41 PM

$BSX Strong Buy

1 · Reply

DragonAlgo Feb. 23 at 11:30 AM

🐉 $BSX PUT — DragonAlgo® Signal Contract: BSX PUT Expiry: 2026-02-27 | Strike: $73.00 | Type: PUT Option Plan (premium): Entry: $0.55 Stop: $0.40 TP1: $0.72 TP2: $0.94 TP3: $1.32 🔗 https://dragonalgo.com

0 · Reply

TheWolfOfSanFran Feb. 23 at 2:49 AM

$BSX give me 50

1 · Reply

Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors

Feb 18, 2026, 10:47 AM EST - 6 days ago

Back on the Radar: Prior Picks Offer Fresh Opportunity

NFLX

Feb 13, 2026, 8:00 AM EST - 11 days ago

Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

Feb 6, 2026, 2:05 PM EST - 18 days ago

Reassessing The Boston Scientific Bull Thesis

Feb 5, 2026, 2:25 PM EST - 19 days ago

What Happened To Boston Scientific Stock?

Feb 5, 2026, 8:18 AM EST - 19 days ago

Boston Scientific Analysts Cut Their Forecasts Following Q4 Results

Feb 4, 2026, 3:30 PM EST - 20 days ago

Boston Scientific Corporation (BSX) Q4 2025 Earnings Call Transcript

Feb 4, 2026, 9:19 AM EST - 20 days ago

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Feb 4, 2026, 8:12 AM EST - 20 days ago

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply.

Feb 4, 2026, 8:02 AM EST - 20 days ago

Boston Scientific shares slide on cautious 2026 revenue forecast

Feb 4, 2026, 6:30 AM EST - 20 days ago

Boston Scientific announces results for fourth quarter and full year 2025

PEN

Feb 4, 2026, 2:02 AM EST - 20 days ago

Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Feb 2, 2026, 5:02 PM EST - 22 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)

Jan 29, 2026, 9:39 AM EST - 26 days ago

Artisan Global Opportunities Fund Q4 2025 Portfolio Update

ARGX BKR COF COIN INSM LEG LHX

Jan 26, 2026, 2:54 PM EST - 4 weeks ago

Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage

APP CMI MNST WYNN

Jan 22, 2026, 12:05 AM EST - 4 weeks ago

Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity

ADBE AMZN AON MELI SAP SPOT

Jan 16, 2026, 10:00 AM EST - 5 weeks ago

How Low Can Boston Scientific Stock Go When Markets Turn Sour?

Jan 15, 2026, 12:05 PM EST - 5 weeks ago

Boston Scientific Corporation (BSX) M&A Call Transcript

Jan 15, 2026, 11:03 AM EST - 5 weeks ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

Jan 15, 2026, 9:11 AM EST - 5 weeks ago

Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach

PEN

Jan 15, 2026, 8:45 AM EST - 5 weeks ago

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.

PEN

Jan 15, 2026, 8:11 AM EST - 5 weeks ago

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments

PEN

Jan 15, 2026, 7:19 AM EST - 5 weeks ago

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

PEN

Jan 15, 2026, 7:07 AM EST - 5 weeks ago

Boston Scientific to buy Penumbra in deal valued at $14.5 billion

PEN

Jan 15, 2026, 7:00 AM EST - 5 weeks ago

Boston Scientific announces agreement to acquire Penumbra, Inc.

PEN

Jan 13, 2026, 3:55 PM EST - 6 weeks ago

Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 7:00 AM EST - 6 weeks ago

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

Jan 2, 2026, 8:00 AM EST - 7 weeks ago

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Dec 28, 2025, 2:40 AM EST - 2 months ago

Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside

Dec 2, 2025, 4:23 PM EST - 3 months ago

Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript

Nov 18, 2025, 11:48 AM EST - 3 months ago

Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Nov 6, 2025, 8:10 AM EST - 3 months ago

Artisan Global Opportunities Fund Q3 2025 Portfolio Update

AMZN DKS INSM LHX SPOT TEAM VRTX

Nov 3, 2025, 8:00 AM EST - 4 months ago

Boston Scientific announces upcoming investor conference schedule

Oct 27, 2025, 1:27 PM EDT - 4 months ago

Baron Health Care Fund Q3 2025 Top Contributors And Detractors

ARGX INSM ISRG LLY RDNT

Oct 23, 2025, 11:34 PM EDT - 4 months ago

Boston Scientific Q3: Operational Improvements Warrant An Upgrade To A Buy

Oct 23, 2025, 9:41 AM EDT - 4 months ago

These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings

Oct 22, 2025, 2:53 PM EDT - 4 months ago

Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript

Oct 22, 2025, 7:36 AM EDT - 4 months ago

Boston Scientific lifts annual profit forecast on strong demand for heart devices

Oct 22, 2025, 6:59 AM EDT - 4 months ago

Boston Scientific Raises Outlook on Continued Cardiovascular Growth

Oct 22, 2025, 6:30 AM EDT - 4 months ago

Boston Scientific announces results for third quarter 2025

Oct 21, 2025, 11:07 AM EDT - 4 months ago

It's time to scoop up undervalued stocks in this critical sector of the economy

ISRG SYK BDX BDYN BIO FEGE JGLO

Oct 17, 2025, 7:09 AM EDT - 4 months ago

Boston Scientific buys Nalu Medical for $533 million

Oct 17, 2025, 7:00 AM EDT - 4 months ago

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

DragonAlgo Feb. 25 at 12:01 AM

0 · Reply

Stonkapedia Feb. 24 at 8:53 PM

$BSX close green you dog. Show signs of life.

0 · Reply

_TP888 Feb. 24 at 6:55 PM

$BSX | $78.00 | Call | Premium: $135K Ask-heavy - aggressive call buyers.

0 · Reply

RonnieJamesDevo Feb. 24 at 5:28 PM

$BSX THY GAP SHALL FILL $BSX

0 · Reply

DragonAlgo Feb. 24 at 5:08 AM

0 · Reply

TitsMcGeee Feb. 23 at 11:44 PM

$BSX @Steward59 Muted. This guys is off his meds. Posts everyday multiple times a day to himself how much he loves this stock, now has flipped sides. Good thing the useless posts seem to continue.

1 · Reply

Steward59 Feb. 23 at 8:50 PM

$BSX don’t trust this company anymore

2 · Reply

BlackjackAces Feb. 23 at 1:41 PM

$BSX Strong Buy

1 · Reply

DragonAlgo Feb. 23 at 11:30 AM

0 · Reply

TheWolfOfSanFran Feb. 23 at 2:49 AM

$BSX give me 50

1 · Reply

DragonAlgo Feb. 21 at 12:01 AM

🐉 $BSX PUT — DragonAlgo® Signal Contract: BSX PUT Expiry: 2026-03-20 | Strike: $70.00 | Type: PUT Option Plan (premium): Entry: $0.70 Stop: $0.50 TP1: $0.91 TP2: $1.19 TP3: $1.68 🔗 https://dragonalgo.com

0 · Reply

CoolE Feb. 20 at 8:16 PM

$BSX few calls in here for a long term swing

0 · Reply

KEVSTER252 Feb. 20 at 7:49 PM

$BSX good spot to add more here.

0 · Reply

ZacksResearch Feb. 20 at 3:44 PM

$BSX vs. $ABT — clear winner in MedTech right now? Abbott edges out Boston Scientific with stronger valuation appeal, solid CGM momentum, and strategic deals that strengthen its investment case. That combo gives it the upper hand in this matchup. 📈 Want to see the full comparison before making your move? Dive in here 👉 https://www.zacks.com/stock/news/2872780/bsx-vs-abt-which-medtech-stock-is-the-better-investment-now?cid=sm-stocktwits-2-2872780-teaser-34410&ADID=SYND_STOCKTWITS_TWEET_2_2872780_TEASER_34410

0 · Reply

ZacksResearch Feb. 20 at 2:44 PM

$ABT vs. $BSX: Which MedTech Giant Offers More Value? 🤔 Abbott's diversified growth and strategic acquisition of Exact Sciences position it well in the high-growth cancer diagnostics market. Despite tariff pressures, Abbott's adjusted gross and operating margins improved in Q4. Discover why ABT might be the smarter pick right now 👉 https://www.zacks.com/stock/news/2872780/bsx-vs-abt-which-medtech-stock-is-the-better-investment-now?cid=sm-stocktwits-2-2872780-body-34409&ADID=SYND_STOCKTWITS_TWEET_2_2872780_BODY_34409

0 · Reply

DragonAlgo Feb. 20 at 5:15 AM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-03-20 | Strike: $75.00 | Type: CALL Option Plan (premium): Entry: $2.92 Stop: $2.11 TP1: $3.80 TP2: $4.97 TP3: $7.02 🔗 https://dragonalgo.com

0 · Reply

SebNo1234 Feb. 19 at 9:29 PM

$BEAT $BSX

1 · Reply

SebNo1234 Feb. 19 at 9:21 PM

$BEAT $BSX

0 · Reply

Bazzzigar Feb. 19 at 12:05 PM

$BSX

0 · Reply

DragonAlgo Feb. 19 at 10:36 AM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-02-20 | Strike: $76.00 | Type: CALL Option Plan (premium): Entry: $0.90 Stop: $0.65 TP1: $1.17 TP2: $1.53 TP3: $2.16 Momentum tape remains active. 🔗 https://dragonalgo.com

0 · Reply

Stonkapedia Feb. 18 at 7:06 PM

$BSX you dog. Do something. Dance Spider.

0 · Reply

DragonAlgo Feb. 18 at 2:32 PM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-02-20 | Strike: $76.50 | Type: CALL Option Plan (premium): Entry: $1.00 Stop: $0.72 TP1: $1.30 TP2: $1.70 TP3: $2.40 🔗 https://dragonalgo.com

0 · Reply

Market Cap	110.67B
Revenue (ttm)	20.07B
Net Income (ttm)	2.90B
EPS (ttm)	N/A
PE Ratio	24.83
Forward PE	21.90
Profit Margin	14.44%
Debt to Equity Ratio	0.49

Volume	14,189,005
Avg Vol	14,393,508
Day's Range	N/A - N/A
Shares Out	1.48B
Stochastic %K	40%
Beta	0.67
Analysts	Strong Sell
Price Target	$107.90